These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 11547834

  • 1. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
    Ederveen AG, Kloosterboer HJ.
    J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
    [Abstract] [Full Text] [Related]

  • 2. Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats.
    Ederveen AG, Spanjers CP, Quaijtaal JH, Kloosterboer HJ.
    J Bone Miner Res; 2001 Sep; 16(9):1674-81. PubMed ID: 11547837
    [Abstract] [Full Text] [Related]

  • 3. Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats.
    Ederveen AG, Kloosterboer HJ.
    J Bone Miner Res; 1999 Nov; 14(11):1963-70. PubMed ID: 10571697
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months.
    Kasugai Y, Ikegami A, Matsuo K, Ohashi M, Sukamoto T, Hosoi T, Ouchi Y, Orimo H.
    Bone; 1998 Feb; 22(2):119-24. PubMed ID: 9477234
    [Abstract] [Full Text] [Related]

  • 6. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
    Yoshitake K, Yokota K, Kasugai Y, Kagawa M, Sukamoto T, Nakamura T.
    Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tibolone and its effects on bone: a review.
    Berning B, Bennink HJ, Fauser BC.
    Climacteric; 2001 Jun; 4(2):120-36. PubMed ID: 11428176
    [Abstract] [Full Text] [Related]

  • 9. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE, Yao W, Kinney JH, Modin G, Balooch M, Wronski TJ.
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [Abstract] [Full Text] [Related]

  • 10. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
    Kippo K, Hannuniemi R, Isaksson P, Laurén L, Osterman T, Peng Z, Tuukkanen J, Kuurtamo P, Väänänen HK, Sellman R.
    J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
    [Abstract] [Full Text] [Related]

  • 11. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [Abstract] [Full Text] [Related]

  • 12. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
    Tivesten A, Movérare-Skrtic S, Chagin A, Venken K, Salmon P, Vanderschueren D, Sävendahl L, Holmäng A, Ohlsson C.
    J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
    Ren P, Ji H, Shao Q, Chen X, Han J, Sun Y.
    Pharmacology; 2007 Nov; 79(3):129-36. PubMed ID: 17179740
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of estrogen and tibolone on bladder histology and estrogen receptors in rats.
    Yang X, Li YZ, Mao Z, Gu P, Shang M.
    Chin Med J (Engl); 2009 Feb 20; 122(4):381-5. PubMed ID: 19302740
    [Abstract] [Full Text] [Related]

  • 16. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J, van Bree R, Van Herck E, Thomas H, Skottner A, Dequeker J, Mosekilde L, Einhorn TA, Bouillon R.
    J Bone Miner Res; 1996 Nov 20; 11(11):1723-35. PubMed ID: 8915780
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA, Ingold P, Venturiere A, Shen V, Green JR.
    J Bone Miner Res; 2008 Apr 20; 23(4):544-51. PubMed ID: 18072878
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K.
    Bone; 2008 Nov 20; 43(5):894-900. PubMed ID: 18687415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.